北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (4): 747-751. doi: 10.3969/j.issn.1671-167X.2018.04.032

• 病例报告 • 上一篇    下一篇

腹膜透析相关嗜酸粒细胞性腹膜炎1例报道并文献复习

蔡士铭,燕宇,赵慧萍△,武蓓,左力,王梅   

  1. (北京大学人民医院肾内科, 北京100044)
  • 出版日期:2018-08-18 发布日期:2018-08-18
  • 通讯作者: 赵慧萍 E-mail: huipingzhao2009@163.com

Peritoneal dialysis-related eosinophilic peritonitis: a case report and literature review

TSAI Shih-ming, YAN Yu, ZHAO Hui-ping△, WU Bei, ZUO Li, WANG Mei   

  1. (Department of Nephrology, Peking University People’s Hospital, Beijing 100044, China)
  • Online:2018-08-18 Published:2018-08-18
  • Contact: ZHAO Hui-ping E-mail: huipingzhao2009@163.com

摘要: 腹膜透析相关性腹膜炎是腹膜透析(peritoneal dialysis)重要且常见的并发症。嗜酸粒细胞性腹膜炎(eosinophilic peritonitis)是一种少见的特殊类型的非感染性腹膜透析相关性腹膜炎,目前病因未明,通常与患者对透析系统的组成成分(如管路或透析液)过敏,或与细菌、真菌、结核等感染相关,临床表现为无症状性腹膜透析液(简称腹透液)混浊、低热、轻度腹痛、腹透液中嗜酸性粒细胞比例增高,多具有自限性。腹膜透析相关嗜酸粒细胞性腹膜炎在1967年由Lee等[1]首次报道。近年来随着腹膜透析技术的推广及发展,嗜酸粒细胞性腹膜炎的病例报道有所增加,但国内鲜有报道。现将我院诊治的1例腹膜透析相关嗜酸粒细胞性腹膜炎患者的情况进行总结报道如下,并结合病例进行文献复习。

关键词: 腹膜透析, 嗜酸粒细胞性腹膜炎, 腹膜透析相关性腹膜炎

Abstract: Peritoneal dialysis (PD)related peritonitis is recognized as a common complication of peritoneal dialysis. Eosinophilic peritonitis is a rare type of non-infection PD-related peritonitis. Eosinophilic peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients was first reported in 1967. The cause of eosinophilic peritonitis is obscure, however it may be related to some etiologies: (1) hypersensitivity to PD materials, including catheter or dialysate; (2) bacteria, fungal or mycobacterium tuberculosis infection. Clinical investigations include asymptomatic cloudy PD effluent, fever, abdominal pain and eosinophil count elevate in PD effluent. Eosinophilic peritonitis is usually mild and self-limited. With the development of PD, more eosinophilic peritonitis cases and researches were reported. Here, we report a patient on CAPD with eosinophilic peritonitis. A 71-year-old female patient developed end-stage renal disease for 4 years and underwent CAPD (2 000 mL of 1.5% dialysis solution with four exchanges daily) for 5 months. With a history of unclean food, she was hospitalized for complaints of diarrhea, fever and cloudy peritoneal effluent for 10 days. Dialysis effluent showed an elevated white blood cell (WBC) count of 1 980 cell/mm3, with 60% polymorphonuclear cells. She was diagnosed as PD-related peritonitis, and therapy was initiated with intraperitoneal ceftazidime 1 g once a day and vancomycin 500 mg every other day. She was admitted to the hospital as the symptoms were not relieved. Her peripheral blood cell count showed a total WBC count of 6 940 cells/mm3, 36.8% eosinophil. Her PD effluent analysis showed turbidity, total WBC count of 1 480 cells/mm3, and 83% polymorphonuclear cells. Her dialysate bacteria culture, fungus culture, polymerase chain reaction for Mycobacterium tuberculosis (TB-PCR), acid-fast stain were all negative. On admission day 4, the treatments were changed to levofloxacin 200 mg once a day and vancomycin 500 mg every other day. After two weeks of antibiotics treatment, patient’s symptoms were not completely improved and her dialysis effluent remained cloudy. Her blood eosinophil count elevated to 36.8%,eosinophil proportion in PD effluent>90% and PD effluent pathological findings showed eosinophil>90%. Eosinophilic peritonitis was diagnosed and a decision was made to give loratadine daily dose of 10 mg orally. The possible reasons might be the patient’s allergy to some components of PD solution or connection systems in the beginning of PD, and this bacterial peritonitis episode, as well as the application of vancomycin, might lead to the fact that eosinophilic peritonitis acutely developed. For there was no improvement in clinical symptoms, loratadine was stopped, and the patient was discharged 18 days later, and received follow-up closely. Two months later, eosinophil count in blood and PD fluid decreased to normal range with no symptom. This case reminds us that in any PD-related peritonitis patient with prolonged symptoms after appropriate antibiotic therapy, and typical clinical symptoms, the diagnosis of eosinophilic peritonitis should be considered. For the count and per-centage of eosinophils are not routinely reported in most laboratories, doctors need to contact the department of laboratory and the department of pathology, to confirm the cell count and proportion of eosinophils in dialysis effluent, so as to make the definite diagnosis, which can not only avoid antibiotics overuse, but also avoid antibiotics-induced eosinophilic peritonitis (such as vancomycin).

Key words: Peritoneal dialysis, Eosinophilic peritonitis, Peritoneal dialysis-related peritonitis

中图分类号: 

  • R572.2
[1] 侯婉音,董捷. 腹膜透析患者获得性肾囊肿出血3例[J]. 北京大学学报(医学版), 2024, 56(3): 546-550.
[2] 乔婕,芦丽霞,何玉婷,门春翠,楚新新,武蓓,赵慧萍,王梅. 真菌性腹膜透析导管出口感染合并隧道感染1例[J]. 北京大学学报(医学版), 2023, 55(4): 748-754.
[3] 唐雯,高峻逸,马辛宇,张超贺,马连韬,王亚沙. 循环神经网络模型在腹膜透析临床预后预测中的初步应用[J]. 北京大学学报(医学版), 2019, 51(3): 602-608.
[4] 段丽萍,郑朝霞,张宇慧,董捷. 腹膜透析患者营养不良-炎症-心血管疾病与认知功能恶化的关系[J]. 北京大学学报(医学版), 2019, 51(3): 510-518.
[5] 李相友,伍军,罗丹,陈晚先,朱戈丽,张艳霞,毕智敏,封宝红. 高糖腹膜透析液对人腹膜间皮细胞NLRP3-IL-1β的影响[J]. 北京大学学报(医学版), 2017, 49(6): 954-960.
[6] 史均宝, 孙庆华, 聂建东, 孙玲华, 张凝, 韩庆烽. 糖尿病腹膜透析患者下肢动脉硬化闭塞症的临床状况分析[J]. 北京大学学报(医学版), 2013, 45(1): 109-113.
[7] 黎丽娴*, 唐雯, 陈伯钧, 汪涛. 腹膜透析患者血压状态与心率变异性关系的横断面研究[J]. 北京大学学报(医学版), 2011, 43(6): 849-854.
[8] 杨志凯, 董捷, 左力. 腹膜透析总水清除量下降速率快是患者死亡的独立危险因素[J]. 北京大学学报(医学版), 2011, 43(6): 844-848.
[9] 王鑫, 汪涛. 持续质量改进对腹膜透析病人高血压的作用[J]. 北京大学学报(医学版), 2004, 36(2): 190-193.
[10] 汪涛. 要加强腹膜透析治疗的管理[J]. 北京大学学报(医学版), 2004, 36(2): 117-118.
[11] 董捷, 汪涛, 韩庆烽, 王海燕. 营养不良、炎症和心血管病对90名腹膜透析病人预后的影响[J]. 北京大学学报(医学版), 2003, 35(6): 645-648.
[12] 王鑫, 汪涛. 腹膜透析患者的钙磷代谢紊乱[J]. 北京大学学报(医学版), 2003, 35(5): 560-560.
[13] 汪涛. 腹膜表面层和腹膜通透性的关系[J]. 北京大学学报(医学版), 2002, 34(5): 471-473.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!